The Cooper Companies, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 2.92B | 3.31B | 3.59B | 3.90B | 4.09B | 5.1% | |
| Cost of Revenue | (966.70M) | (1.17B) | (1.24B) | (1.30B) | (1.61B) | 23.8% | |
Gross Profit | 1.96B | 2.14B | 2.36B | 2.60B | 2.48B | -4.3% | |
| Operating Expenses | |||||||
| Research & Development | (92.70M) | (110.30M) | (137.40M) | (155.10M) | (172.20M) | 11.0% | |
| Selling, General & Administrative | (1.21B) | (1.34B) | (1.50B) | (1.53B) | (1.63B) | 6.1% | |
| Depreciation & Amortization | (309.30M) | (346.10M) | (367.70M) | (375.10M) | (423.00M) | 12.8% | |
Operating Income (EBIT) | 505.80M | 507.60M | 533.10M | 705.70M | 682.90M | -3.2% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (23.10M) | (57.30M) | (105.30M) | (114.30M) | (100.00M) | -12.5% | |
| Other Income/Expenses (Net) | -14.30M | -32.30M | -120.20M | -123.40M | -116.40M | -5.7% | |
Income Before Tax | 491.50M | 475.30M | 412.90M | 582.30M | 566.50M | -2.7% | |
| Income Tax Expense | (2.45B) | (89.50M) | (118.70M) | (190.00M) | (191.60M) | 0.8% | |
Net Income | 2.94B | 385.80M | 294.20M | 392.30M | 374.90M | -4.4% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $60 | $2 | $1 | $2 | $2 | -4.6% | |
| Weighted Avg Shares Outstanding | 197.20M | 197.20M | 198.00M | 198.90M | 200.00M | 0.6% | |
| Weighted Avg Shares Outstanding (Diluted) | 199.40M | 198.80M | 199.20M | 200.40M | 200.00M | -0.2% | |
EBITDA | 823.90M | 878.70M | 885.90M | 1.07B | 1.05B | -1.7% |
Explore COO
COO in the Healthcare
Large Cap